What to Know About Leqembi, the Alzheimer’s Drug Permitted by the Food and drug administration
[ad_1] On Thursday, the Foodstuff and Drug Administration gave whole acceptance to the drug Leqembi for patients who are in the early phases of Alzheimer’s ailment, and Medicare claimed it would protect 80 percent of the value of the $26,500-per-calendar year medication. The selections by the two federal organizations will vastly maximize obtain to the…